https://www.selleckchem.com/pr....oducts/filanesib.htm
94], p 0.05; I2 = 72%, p 0.05). Non-survivor group had a pooled higher mean difference of fibrinogen values on admission (MD = 0.48 [95% CI 0.13 to 0.83], p 0.05; I2 = 38%, p = 0.18). Higher FDP on admission was found in poor outcome (composite of severity, critically ill, and mortality) compared to good outcome (4 studies, MD = 4.84 [95% CI 0.75 to 8.93], p 0.05; I2 = 86%, p 0.05). Elevated fibrinogen and FDP level on admission were associated with an increase risk of poor outcome in COVID-19 patients. Elevat
Like
Comment
Share
